180 related articles for article (PubMed ID: 33006027)
1. Retrospective analysis of bacterial colonization of necrotic bone and antibiotic resistance in 98 patients with medication-related osteonecrosis of the jaw (MRONJ).
Ewald F; Wuesthoff F; Koehnke R; Friedrich RE; Gosau M; Smeets R; Rohde H; Assaf AT
Clin Oral Investig; 2021 May; 25(5):2801-2809. PubMed ID: 33006027
[TBL] [Abstract][Full Text] [Related]
2. CT imaging features of antiresorptive agent-related osteonecrosis of the jaw/medication-related osteonecrosis of the jaw.
Baba A; Goto TK; Ojiri H; Takagiwa M; Hiraga C; Okamura M; Hasegawa S; Okuyama Y; Ogino N; Yamauchi H; Kobashi Y; Yamazoe S; Munetomo Y; Mogami T; Nomura T
Dentomaxillofac Radiol; 2018 May; 47(4):20170323. PubMed ID: 29365278
[TBL] [Abstract][Full Text] [Related]
3. Microbial diversity in infections of patients with medication-related osteonecrosis of the jaw.
Zirk M; Wenzel C; Buller J; Zöller JE; Zinser M; Peters F
Clin Oral Investig; 2019 May; 23(5):2143-2151. PubMed ID: 30276516
[TBL] [Abstract][Full Text] [Related]
4. Histologic analysis of medication-related osteonecrosis of the jaw compared with antiresorptive-exposed bone and other infectious, inflammatory, and necrotic jaw diseases.
Yuan A; Munz A; Reinert S; Hoefert S
Oral Surg Oral Med Oral Pathol Oral Radiol; 2020 Feb; 129(2):133-140. PubMed ID: 31606424
[TBL] [Abstract][Full Text] [Related]
5. The Prevention of Medication-related Osteonecrosis of the Jaw.
Poxleitner P; Engelhardt M; Schmelzeisen R; Voss P
Dtsch Arztebl Int; 2017 Feb; 114(5):63-69. PubMed ID: 28241916
[TBL] [Abstract][Full Text] [Related]
6. Indigenous Microbiota Protects against Inflammation-Induced Osteonecrosis.
Williams DW; Vuong HE; Kim S; Lenon A; Ho K; Hsiao EY; Sung EC; Kim RH
J Dent Res; 2020 Jun; 99(6):676-684. PubMed ID: 32109361
[TBL] [Abstract][Full Text] [Related]
7. Medication-related osteonecrosis of the jaw: risk factors in patients under biphosphonate versus patients under antiresorptive-antiangiogenic drugs.
Ghidini G; Manfredi M; Giovannacci I; Mergoni G; Sarraj A; Mureddu M; Giunta G; Bonanini M; Meleti M; Vescovi P
Minerva Stomatol; 2017 Aug; 66(4):135-140. PubMed ID: 28497661
[TBL] [Abstract][Full Text] [Related]
8. [Position paper on medication-related osteonecrosis of the jaw (MRONJ)].
Svejda B; Muschitz Ch; Gruber R; Brandtner Ch; Svejda Ch; Gasser RW; Santler G; Dimai HP
Wien Med Wochenschr; 2016 Feb; 166(1-2):68-74. PubMed ID: 26847441
[TBL] [Abstract][Full Text] [Related]
9. Dental implants as risk factors for patients with medication-related osteonecrosis of the jaws (MRONJ).
Pichardo SEC; van der Hee JG; Fiocco M; Appelman-Dijkstra NM; van Merkesteyn JPR
Br J Oral Maxillofac Surg; 2020 Sep; 58(7):771-776. PubMed ID: 32631756
[TBL] [Abstract][Full Text] [Related]
10. Antiresorptive Agent-Related Osteonecrosis of the Jaw (ARONJ): A Twist of Fate in the Bone.
Shibahara T
Tohoku J Exp Med; 2019 Feb; 247(2):75-86. PubMed ID: 30713280
[TBL] [Abstract][Full Text] [Related]
11. Actinomyces and MRONJ: A retrospective study and a literature review.
Cerrato A; Zanette G; Boccuto M; Angelini A; Valente M; Bacci C
J Stomatol Oral Maxillofac Surg; 2021 Nov; 122(5):499-504. PubMed ID: 32827811
[TBL] [Abstract][Full Text] [Related]
12. Can medication-related osteonecrosis of the jaw be attributed to specific microorganisms through oral microbiota analyses? A preliminary study.
Kim HY; Jung YS; Park W; Choi YJ; Kim JY
BMC Oral Health; 2024 Feb; 24(1):160. PubMed ID: 38302952
[TBL] [Abstract][Full Text] [Related]
13. Medication-related osteonecrosis of the jaw: An update on the memorial sloan kettering cancer center experience and the role of premedication dental evaluation in prevention.
Owosho AA; Liang STY; Sax AZ; Wu K; Yom SK; Huryn JM; Estilo CL
Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 May; 125(5):440-445. PubMed ID: 29580668
[TBL] [Abstract][Full Text] [Related]
14. Clarithromycin as the empiric antibiotic therapy for medication-related osteonecrosis of the jaw in multiple myeloma patients.
Zadik Y
Oral Oncol; 2018 Sep; 84():104-105. PubMed ID: 30115467
[TBL] [Abstract][Full Text] [Related]
15. Medication-related osteonecrosis of the jaw-like lesions in rodents: A comprehensive systematic review and meta-analysis.
Kuroshima S; Sasaki M; Murata H; Sawase T
Gerodontology; 2019 Dec; 36(4):313-324. PubMed ID: 31373407
[TBL] [Abstract][Full Text] [Related]
16. Necrotizing periodontitis or medication-related osteonecrosis of the jaw (MRONJ) in a patient receiving Bemcentinib-a case report.
Bumm CV; Folwaczny M; Wölfle UC
Oral Maxillofac Surg; 2020 Sep; 24(3):353-358. PubMed ID: 32440898
[TBL] [Abstract][Full Text] [Related]
17. Medication-related osteonecrosis of the jaw after once-a-year intravenous zoledronic acid infusion for osteoporosis: Report of eight cases.
Favia G; Tempesta A; Limongelli L; Crincoli V; Maiorano E
Quintessence Int; 2016; 47(5):433-40. PubMed ID: 26665262
[TBL] [Abstract][Full Text] [Related]
18. Surgical therapy for medication-related osteonecrosis of the jaw in osteoporotic patients treated with antiresorptive agents.
Hauer L; Jambura J; Hrusak D; Chalupova M; Posta P; Rusnak S; Vyskocil V
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2020 Mar; 164(1):100-107. PubMed ID: 30647474
[TBL] [Abstract][Full Text] [Related]
19. Investigation of clindamycin concentrations in human plasma and jawbone tissue in patients with osteonecrosis of the jaw: A prospective trial.
Straub A; Stapf M; Brands RC; Kübler AC; Lâm TT; Vollmer A; Gubik S; Scherf-Clavel O; Hartmann S
J Craniomaxillofac Surg; 2024 Mar; 52(3):355-362. PubMed ID: 38368214
[TBL] [Abstract][Full Text] [Related]
20. Medication-related osteonecrosis of the jaw: Osteoclast profile in comparison with osteoradionecrosis of the jaw and osteomyelitis of the jaw.
Ngoc Thuy Tran V; Chaisuparat R
J Oral Pathol Med; 2021 Aug; 50(7):731-740. PubMed ID: 34038006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
